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Available online 12 March 2008Xenopus laevis Aurora-A is phosphorylated in vivo onto three amino acids: Ser53, Thr295 and Ser349. The
activation of the kinase depends on its autophosphorylation on Thr295 within the T-loop. The
phosphorylation of Ser53 by still unknown kinase(s) prevents its degradation. The present work focused
on the regulation of Aurora-A function via Ser349 phosphorylation. Mutagenesis of Ser349 to alanine
(S349A) had few impact in vitro on the capability of the kinase to autophosphorylate as well as on its
activity. These data in addition to in gel kinase assays and site-speciﬁc proteolytic digestion experiments
prove that Ser349 is clearly neither a primary autophosphorylation site, nor an autophosphorylation site
depending on the priming phosphorylation of Thr295. Using speciﬁc antibodies, we also show that the
phosphorylation of Aurora-A Ser349 is a physiological event during Xenopus oocyte maturation triggered by
progesterone. A peak of phosphorylation paralleled the decrease of Aurora activity observed between
meiosis I and II. In response to progesterone, X. laevis stage VI oocytes microinjected with the Aurora-A
S349A mutant proceeded normally to germinal vesicle breakdown (GVBD), but degenerated rapidly soon
after. Since phosphorylation of Ser349 is responsible for a decrease in kinase activity, our results suggest that
a down-regulation of Aurora-A activity involving Ser349 phosphorylation is required in the process of
maturation.
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Aurora-A is a member of the serine/threonine kinase family
involved in centrosome maturation, spindle formation and stability
(Giet and Prigent, 2000; Roghi et al., 1998). In somatic cells, Aurora-A
defects can lead to abnormal chromosome segregation and cell cycle
arrest (Katayama et al., 2001). Its overexpression is sufﬁcient to
transform cells, identifying Aurora-A as an oncogene (Bischoff et al.,
1998; Zhou et al., 1998). The protein is synthesized throughout the cell
cycle to reach amaximum level at theMphase. Upon exit frommitosis,
Aurora-A is degraded through a proteasome-dependent pathway
mediated by APC/cdh1 (Arlot-Bonnemains et al., 2001; Castro et al.,
2002a; Walter et al., 2000). Aurora-A contains two sequences
necessary for its degradation: a Destruction box (D-box) in its C-
terminal end and a Destruction box Activating Domain (DAD or A-box)
in its N-terminal end (Castro et al., 2002b; Littlepage and Ruderman,
2002).
In Xenopus laevis, Aurora-A is also required for oocyte maturation
(Andresson and Ruderman,1998;Ma et al., 2003;Mendez et al., 2000).
The kinase is activated after progesterone stimulation, around the time
when MPF (maturation promoting factor) activation occurs. But, thenes1.fr (Y. Arlot-Bonnemains).
l rights reserved.precise timing and function of Aurora-A activation in the regulation of
oocyte maturation remain controversial (Andresson and Ruderman,
1998; Frank-Vaillant et al., 2000). Nevertheless, Aurora-A has been
shown to phosphorylate and activate CPEB, a cytoplasmic polyadeny-
lation factor important for controlling the translation of various
mRNAs during maturation (Mendez et al., 2000), as well as maskin
(Pascreau et al., 2005).
X. laevisAurora-A incubated in the presence ofMphase extracts has
been found phosphorylated on three sites: Ser53 in the DAD box,
Thr295 in the T-loop and Ser349 in the C-terminal end of the catalytic
domain (Fig. 1A) (Littlepage et al., 2002). Fourteen residues were also
found phosphorylated in recombinant Aurora-A (puriﬁed from bacte-
ria), four of themwere present in the additional N-terminal 49 amino
acid long tail containing the His6 tag. The authors suggested that the
sites were likely to be autophosphorylation sites (Haydon et al.,
2003).
Inmany kinases, the phosphorylation of a Thr residue located in the
activation-loop of the kinase domain is required for constitutive kinase
autophosphorylation (Huse and Kuriyan, 2002). Autophosphorylation
within the T loop induces large conformational changes which allow
the kinase to switch from inactive to active state (Johnson et al., 1996).
The activity of Xenopus Aurora-A depends on the autophosphorylation
of the T-loop Thr295 residue. If the autophosphorylation of Thr295 is
required for the kinase activity of Aurora-A, it has to benoted that some
physiological substrates, such as TPX2, does enhance the autophos-
Fig.1. Analysis of the autophosphorylation and activity of wild type andmutant Aurora-A(His)6 proteins. (A) Organisation of Aurora-A andmutagenesis sites. The central domain (grey) contains the catalytic domain. The underlined amino acids
correspond to the mutated amino acids. (B) Recombinant Aurora-A proteins (2 μg) were incubated in the presence of 5 μCi [32P]ATP without substrate (group a, autophosphorylation) or in presence of 10 μg of GST-p17 (group b). The mixture
was electrophoresed on a 12.5% polyacrylamide gel. The gel was stained with Coomassie Blue (lower panel for each group) and kinase activity was monitored by autoradiography (upper panel for each group). The autoradiography exposure
times of gels containing kinase assays were ﬁve times shorter for the GST-p17 substrate than for the autophosphorylation. (C) In-gel kinase assays performed in absence or presence of protein substrates embeded in the gel: no protein (lane 1),
K169R (lane 2), T294A–T295A–S349A (lane 3), T294A–T295A (lane 4) or T295A (lane 5) as substrates. Recombinant wild type Aurora-A (3 μg) was electrophoresed on the gels. The phosphorylation assay was then performed on the gels. The
radioactivity incorporated in the substrates was visualized by autoradiography. (D) 10 μg of recombinant wild type (lane 1) or S349A mutant (lane 3) Aurora-Awere autophosphorylated in the presence of 5 μCi [32P]ATP. The proteins were then
treated with Factor Xa (lanes 2 and 4). All the samples were analyzed on a 10–20% Tris–Trycine gel. The gel was stained with Coomassie Blue (upper panel) and autoradiographed (lower panel). (E) Quantiﬁcation of the different bands was
performed using the Image Quant software.
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525G. Pascreau et al. / Developmental Biology 317 (2008) 523–530phorylation process (Eyers and Maller, 2003; Kufer et al., 2002; Tsai
et al., 2003).
The sequence (…LGPS*NVP…) around Ser53 differs from (K/R)XX
(S/T), the putative consensus site for phosphorylation by Aurora-A,
suggesting that the site is probably not an autophosphorylation site.
Mutations of Ser53 have revealed that the phosphorylation of this
amino acid is not involved in the regulation of the kinase activity but
rather controls the degradation of the protein (Littlepage et al., 2002).
The Ser53 residue is indeed locatedwithin an A box, a short N terminal
region required for Aurora Adestruction. Its phosphorylation stabilizes
Aurora-A, and its mutation into an aspartic residue which mimics the
effect of phosphorylation, prevents the degradation of Aurora-A
through APC/Cdh1 (Littlepage and Ruderman, 2002).
The Ser349 residue is included in a characteristic Aurora-A con-
sensus sequence (…RRIS*K…) (Sarkissian et al., 2004). Ser349 phos-
phorylation has not been investigated in vivo, and the few data
suggests a role of this modiﬁcation in the regulation of the kinase
activity. It has been proposed that Ser349 autophosphorylation is an
event occurring after a primary phosphorylation on Ser290/291 by the
Glycogen synthase kinase 3 (GSK3) (Sarkissian et al., 2004). The
phosphorylation of Ser349 reduces the activity of the kinase, and its
mutation into an Asp residue completely abolishes the kinase activity
(Littlepage et al., 2002; Sarkissian et al., 2004). In contrast, the kinase
puriﬁed from bacteria was found entirely phosphorylated on Ser349
but paradoxically still fully active (Haydon et al., 2003).
These discrepancies lead us to reinvestigate the phosphorylation of
Ser349 both in vitro and in vivo. Our results clearly demonstrate that
Ser349 is neither a primary autophosphorylation site nor a site
requiring the primary Thr295 autophosphorylation. We also show
that, in vitro, Xl-Aurora-A can be speciﬁcally phosphorylated on Ser
349 by the X. laevis p21 activated kinase (xPAK1), a member of the
Xenopus Ste20/PAK protein kinases involved in the arrest of G2/
prophase oocytes. We conﬁrm that Ser349 phosphorylation reduces
the kinase activity. In vivo, using a speciﬁc anti-phospho-Ser49
antibody, we show that Aurora-A is phosphorylated on Ser349 in X.
laevis stage VI oocytes and that the level of this phosphorylation
ﬂuctuates during their maturation after progesterone stimulation.
Microinjection studies of various recombinant Aurora-A mutants led
us to conclude that the phosphorylation of Ser349 is essential to allow
proper progression of oocyte maturation.
Materials and methods
Antibodies
The monoclonal antibodies against Xl-Aurora-A (1C1) and against Xl-Aurora-A-
(His)6 (6E3) were produced in the laboratory (Roghi et al., 1998). The polyclonal
antibodies against anti-Xl-Aurora-A and cdc6 were kind gifts from T. Lorca (CRBM,
Montpellier, France) and M. Mechali (IGH, Montpellier, France) respectively. The
polyclonal antibody directed against the phospho-Ser349 of the Xl-Aurora-A protein
was produced by Eurogentec (Searing, Belgium) using the pentadecapeptide GETYRRIS
(P)VEFQYP as antigen.
Site directed mutagenesis
The mutant forms of Aurora-A(His)6 were obtained by PCR ampliﬁcation, using the
pET21a-wt-Aurora-A(His)6 construction as a DNA template. The mutations were pe-
formed by the ﬁrst round of PCR in the presence of the sense (S) (CCTGGCGCTG-
AAAGTCCTGT) or the antisense (AS) (CCCCTCACTTTTGGAAGG) primers associated with
the primer corresponding to the expected mutations described:
S349A: Sense: TTCAACCTTTGCAATACGTCTGTA
Antisense: TACAGACGTATTGCAAAGGTTGAA
T295A: Sense: GCTCCATCCTCCAGGAGGACCGCTCTGTGTGGAACACTGG
Antisense: CCACACAGAGCGGTCCTCCTGGAGGATGGAGCATGCAC
T294AT295A: Sense: ATCCTCCAGGAGGGCCGCTCTGT
Antisense: ACAGAGCGGCCCTCCTGGAGGAT
The second PCR was performed with both the sense primer and the antisense
primer, using the two products from the ﬁrst round of PCR as the DNA template. PCR
products were directly cloned in a pET21a vector (Novagen).The T294A–T295A–S349A mutant was obtained by insertion of the NsiI/NcoI
fragment of S349A mutant (containing the S349A mutation) into the T294A–T295A
construction cut with the same enzymes.
Puriﬁcation of recombinant proteins
All histidine-tagged recombinant Aurora-A proteins were produced from BL21
(DE3)-pLysS and puriﬁed by a Ni-NTA-agarose afﬁnity chromatography following the
manufacturer’s instructions (QiagenSA).
The recombinant GST-p17 and GST-GSK-3 proteins were puriﬁed as previously
described from BL21(DE3)-pLysS transformed with constructions in pGEX-4T (Fisher
et al., 1999; Pascreau et al., 2005). All constructs were sequenced in full (Genome
Express). Cloning and puriﬁcation of pMal-xPAK1 and its K279R mutant have been
reported previously (Faure et al., 1999).
In vitro kinase assay
The assays were performed in 20 μL of kinase buffer (50 mM Tris–HCl pH 7.5,
50 mM NaCl, 1 mM DTT, 10 mM MgCl2, 10 μM ATP) in the presence of 5 μCi [γ-32P]
ATP at 3000 Ci/mmol and different recombinant kinase proteins (2 μg) or
immunoprecipitates, with or without 10 μg of the appropriate protein substrate.
Incubations were performed at 30 °C for 10 min. Ten microliters of the incubate
were mixed with 10 μL of 2×-Laemmli sample buffer and the proteins were sepa-
rated on a 12.5% SDS polyacrylamide gel. Gel was stained with Coomassie Blue and
autoradiographed.
In gel kinase assay
Recombinant wild type Aurora-A protein was electrophoresed onto a 12.5% SDS-
polyacrylamide gel, containing (or not containing) 500 μg/mL of one of the
following Aurora proteins: K169R, T295A, T294A–T295A, and T294A–T295A–S349A.
The phosphorylation reactions were performed in the presence of 100 μCi [γ-32P]
ATP at 3000 Ci/mmol. The gels were processed as previously described (Wooten,
2002).
Cleavage of the autophosphorylated Aurora-A by Factor Xa
WT and S349A Aurora-A recombinant proteins autophosphorylated in presence
of [32P] ATP were treated with 0.6 units of Factor Xa (Qiagen) in the digestion buffer
(50 mM Tris–HCl pH 8, 100 mM NaCl, 5 mM CaCl2) during 1 h at 37 °C. The reaction
was stopped by addition of Laemmli buffer and the proteins were separated on a
10–20% Tris–Tricine gel (Biorad). Gel was stained with Coomassie blue and
autoradiographed.
Oocyte experimentations
Xenopus oocytes were enzymatically isolated from fragments of ovaries which
were previously treated with 40 mg of dispase in 100 mL of OR-2 medium (10 mM
Hepes pH 7.6, 82.5 mM NaCl, 2.5 mM KCl, 1 mM MgCl2) for 3 h, then in 10,000 units of
collagenase in 100 mL of OR-2 medium for 45 min. Isolated oocytes were then directly
recovered and stored for 12 h at 16 °C in Merriam buffer (Merriam, 1971). Groups of 20
oocytes were injected with 368 ng of wild type or mutant proteins, or with the dilution
buffer (Merriam buffer) as a control. After injections, the oocytes were incubated with
3×10−6 M of progesterone at 21 °C. GVBD was monitored by the appearance of the
white spot. Immunoprecipitation experiments and kinase activity assays were
performed using extracts prepared from oocytes at different stage of maturation as
previously described (Chen and Murray, 1997).
Immunoprecipitations
10 μL of dried Afﬁprep protein-A (BioRad) werewashedwith 500 μL of Immunopure
(A) IgG binding buffer (IBB-Pierce) and were incubated for 2 h at 4 °C with 500 μL of 1C1
antibody (dil: 1/20) in IBB (dil: 1/2), and then washed twice with 500 μL TBS (50 mM
Tris–HCl pH 7.5; 150mMNaCl). Beads were then incubatedwith a 10 equivalent oocytes
extract for 2 h at 4 °C on awheel. The beads were washed once in 500 μL of 0.5 mMNaCl
and 5 times with 500 μL TBST (TBS–0.05% Tween 20). Bound proteins were eluted in
10 μL of 2×-Laemmli sample buffer.
Western blotting
Proteins were loaded on a 12.5% polyacrylamide gel and transferred onto a
nitrocellulose membrane using the Biorad system. The membranes were washed with
TBST (50 mM Tris–HCl pH 7.5; 150 mM NaCl; 0.05% Tween 20) and saturated with 5%
low fat milk in TBST for 2 h at room temperature. The membranes were incubated
overnight at 4 °C in 2.5% low fat milk in TBST with the proper antibody: anti-Xl-Aurora-
A 1C1 monoclonal antibody (dil: 1/200), polyclonal antibodies raised against phospho-
Ser349 Xl-Aurora-A (dil: 1/5000), or cdc6 (dil: 1/2000). After incubation with
appropriate secondary antibodies conjugated with horseradish peroxidase (dil: 1/
50,000; Jackson Immuno-Research Laboratories), the western blot chemiluminescence
Super Signal kit (Pierce) was used for revelation.
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Aurora-A autophosphorylation sites
In order to validate our assay used to analyse the autophospho-
rylation sites of Aurora-A, wild type andmutant forms of Aurora-(His)6
were produced in bacteria. Mutant forms bear single or combined
point mutation of Thr295 and Ser349 (Fig. 1A).
Autophosphorylation of the various forms of Aurora-A was ana-
lyzed after incubation of the enzymes in presence of [32P] ATP in an
adequate buffer and electrophoretic separation (Fig. 1B, group a). The
autoradiography revealed incorporation of 32P in the wild-type kinase
and the S349A mutant (lanes 1 and 3). This was accompanied by a
decrease in the electrophoretic mobility of both proteins. In contrast,
none of the other mutants had incorporated radioactivity.
The kinase activity of the various forms of recombinant Aurora-
(His)6was determinedusingGST-p17, a proteinpreviously described as
a physiological substrate of Aurora-A (Pascreau et al., 2005), in pre-
sence of [32P] ATP in an adequate buffer (Fig. 1B, group b). The K169R
and the T295A mutations had a dramatic effect on the activity of the
kinase. The K169R mutation completely abolished the activity of the
kinase (lane 2). The activity of the T295Amutant was also dramatically
reduced but a residual kinase activity was observed (lane 4). This
residual activity was completely lost in the double T294A–T295A
mutant inwhich the adjacent Thr294was alsomutated into an alanine
(lane 5). In contrast, the kinase with the Ser349 replaced by an alanine
was fully active (lane 3). We also tested the activity of all mutants with
two other substrates MPB and H3, and observed similar results than
with GST-p17 (data not shown). We ﬁnally carried out all kinase
activity in the presence of the GST-p17 substrate.
Trans-phosphorylation analysis by in-gel kinase assay
To determinewhether Aurora-AThr295 and Ser349 residues can be
trans-phosphorylated by Aurora-A, we performed an “in gel kinase
assay”, amethod currently used to identify kinase substrates. The assay
consisted in electrophoresing an active Aurora kinase in a polyacry-
lamide gel cast with an another form of Aurora-A kinase which acts as
the substrate for the kinase reaction. As the kinase assay is performed
in the gel, the substrates inside the gel have to be devoid of any
autophosphorylation and kinase activity. Three different inactive
recombinant Aurora-A mutants were used as substrates in the assay:
the K169R mutant that possesses both Thr295 and Ser349 residues
available for phosphorylation; the T294A–T295A mutant where
solely the Ser349 residue is available for phosphorylation; and the
T294A–T295A–S349A with none of the two phosphorylable residues.
The inactive Aurora-A kinases were embedded in SDS-polyacryla-
mide gels at the concentration of 500 μg/mL. The recombinant active
wild type Aurora-A kinase (3 μg/lane) was electrophoresed on the
gel. Finally, after successive steps of denaturation and renaturation,
the gel was incubated in the presence of [32P] ATP in an adequate
buffer to determine whether the mutant form of Aurora-A em-
bedded in the gel could be phosphorylated by the active Aurora-A
(Fig. 1C).
No radioactive signal was observed in the absence of proteinwithin
the gel (lane 1). A strong signal was observed in the gel cast with the
dead K169R kinase, indicating that the inactive substrate kinase was
trans-phosphorylated by the active Aurora-A (lane 2). Such signal was
not observed when a similar in-gel assay was performed with the
inactive K169R kinase as the enzyme (data not shown). In contrast, the
wild-type Aurora-A kinase was unable to trans-phosphorylate the
three mutants bearing the T295A mutation (lanes 3,4,5) whether the
Ser349 was available (lanes 4,5) or not (lane 3). These results clearly
indicate that an active Aurora-A kinase was able to trans-phosphor-
ylate the Thr295 residue present in another kinase molecule, but not
the Ser349 residue.Site-speciﬁc proteolytic digestion of autophosphorylated Aurora-A kinase
It is now clear that Thr295 is an autophosphorylation site. It is also
obvious from the above results that Ser349 is not a primary autophos-
phorylation site. Nevertheless, it is still conceivable that the primary
autophosphorylation of Thr295 leads to structural remodelling that
renders the Ser349 susceptible to auto- or trans-phosphorylation. To
check this hypothesis, the recombinant wild type Aurora-A and the
S349Amutantwere autophosphorylated in vitro in the presence of [32P]
ATP. Then, the proteins were subjected to a proteolytic cleavage using
Factor Xa: this protease generates a 34 kDa fragment containing the
Thr295 (Aurora-A-34 kDa), and a 11 kDa (Aurora-A-11 kDa) fragment
enclosing the Ser 349. As shown in Fig. 1D, in our experimental
conditions, the cleavage of Aurora-A was not complete. In addition to
the 34 and 11 kDa fragments, some native 45 kDa protein was still
observed. The autoradiography shows that in absence of digestion both
the wild type and the S349A mutant proteins had incorporated
radioactivity (Fig. 1D lanes 1 and 3). After digestion, radioactivity was
found associated to the 34 kDa fragment of Factor Xa-cleaved Aurora-A
as well as to the 45 kDa undigested protein. But no radioactivity was
found associated to the 11 kDa fragment (Fig.1D lanes 2 and 4, panel b—
see quantiﬁcation in Fig. 1E). This clearly demonstrates that, when an
active Aurora-A kinase is incubated in presence of ATP, Ser349 is not
phosphorylated while Thr295 is.
Altogether our results demonstrate that the Aurora-A Ser349 is
neither a primary autophosphorylation site, nor an autophosphoryla-
tion site depending on the priming phosphorylation of Thr295.
Impact of Ser 349 phosphorylation on Aurora-A kinase activity
A previous report has shown that Ser349 is phosphorylated in the
presence of mitotic extract (Littlepage et al., 2002). It has been
proposed that the phosphorylation of this residue might be an
autophosphorylation event requiring an initial phosphorylation of
Ser290/291 by the glycogen synthase kinase 3 (Sarkissian et al., 2004).
However, these results did not rule out the possibility that Ser349 is a
Xl-GSK3 phosphorylation site requiring the primary phosphorylation
of Ser290/291. Nevertheless, it was observed in this last study that the
phosphorylation of Aurora-A by Xl-GSK3 reduced by 50% the activity
of the kinase. However, it is not clear whether the Xl-GSK3-induced
drop of activity is due to the sole phosphorylation of Ser349 or if it is
the consequence of the double phosphorylation on Ser290/291 and
Ser349. The S349D mutant where the Ser349 is replaced by an Asp
residue (to mimick phosphorylation; mutation S/D) was found fully
active in our hand (data not shown) while it has been reported to be
fully inactive in other laboratories (Littlepage et al., 2002; Sarkissian et
al., 2004). However, these last results were in apparent contradiction
with another work reporting that the wild-type kinase puriﬁed from
bacteria is entirely phosphorylated on Ser349 but still active (Haydon
et al., 2003). Altogether, these studies do not allow to draw a clear
ﬁgure of the impact of the phosphorylation of Ser349 on the activity of
the enzyme.
As we demonstrated that the Ser 349 is not an autophosphoryla-
tion site, we searched for a kinase able to phosphorylate Aurora-A on
Ser349. This residue is included in a sequence RISK similar to a con-
sensus domain …xxRXSXxx… found in substrates of the Xenopus
PAK1 kinase, a kinase known to regulate the dynamics of the micro-
tubule network and to be involved in the regulation of the oocyte
maturation process (Faure et al., 1997). Recently, Zhao and collabora-
tors reported the phosphorylation of both Thr288 and Ser 342 of
human Aurora-A (which are equivalent to Thr295 and Ser349,
respectively, in Xl-Aurora-A) by hs-PAK1 (Zhao et al., 2005).
We studied the phosphorylation of Aurora-A by xPAK1 by incu-
bating various forms of Aurora-A with [32P]ATP in the presence of
either active xPAK1 (Fig. 2A lanes 1, 3 and 5) or inactive K279R xPAK1
(Fig. 2A lanes 2 and 4). Inactive recombinantmutant Aurora-A proteins
Fig. 2. In vitro phosphorylation of Aurora-A Ser349. (A) Mutant K/R, T294A–T295A, and
T294A–T295A–S349A Aurora-A(His)6 were incubated with puriﬁed active xPAK1
protein in presence of [32P]ATP (lanes 1, 3 and 5). The same proteins were subjected
to the same reaction in the presence of K279R xPAK1 inactive (lanes 2 and 4). Samples
were separated by SDS-PAGE and the gel was stained with Coomassie blue (lower
panel). The Aurora-A(His)6 phosphorylation for each protein was analyzed by
autoradiography (upper panel). A western blot was performed with the antibody
against the phospho-Ser 349 Aurora-A (middle panel). (B) Wild type Aurora-A(His)6
was ﬁrst phosphorylated in presence (lane 1) of puriﬁed xPAK1 (lane 2) or with Xl-GSK3
(lane 3). Then the activity of Aurora-A is measured in presence of [γ-32P]ATP and the
substrate GST-p17, Histone H3 and MBP. The assay was analyzed on a 12.5% SDS-PAGE.
The gel was stained with Coomassie Blue and autoradiographed.
Fig. 3. In vivo phosphorylation of Aurora-A Ser349. (A) Cytolosic extracts were prepared
from oocytes collected at different stage of maturation. Aurora-A was immunopreci-
pitated with the speciﬁc 1C1 antibody directed against the native Aurora-A protein and
analysed by western blot to evaluate the amount of protein (middle panel). The
phosphorylation of the Ser349 was analyzed with the antibody anti phospho-Ser349-
Aurora-A (upper panel). The activity of the kinase was tested in the immunoprecipitate
using the GST-p17 as a substrate (lowermiddle panel). The immunoprecipitated Aurora-
A protein was also analysed using a preadsorbed antibody with the Ser349 phos-
phorylated Aurora-A (His)6 (lower panel). (B) Quantiﬁcation of the activity of the kinase,
the phosphorylation of Ser349 Aurora-A and the amount of Aurora A was performed
with the ImageQuant software. Results are expressed as means±standard deviation of
three different experiments.
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eliminate possible autophosphorylation. The active xPAK1 phosphory-
lated the K169R and T294A–T295Amutants (Fig. 2A lanes 1 and 3). The
mutants did not incorporate 32P in presence of the inactive K279R
xPAK1 (Fig. 2A lanes 2 and 4). In contrast, xPAK1 did not phosphorylate
the T294A–T295A–S349Amutant. These results suggested that Ser349
was the only residue phosphorylated by xPAK1 in vitro. A speciﬁc
antiserum elicited against a peptide containing the Phospho-Ser349
residuewas thenused to conﬁrm thephosphorylation of the residue by
western blot analysis. Phospho-Ser349 was detected in the K169R
mutant incubated with the active xPAK1, but not in the protein incu-
bated with the inactive kinase (K279R xPAK1) (Fig. 2A lane 1, middle
panel). Phospho-Ser349 was also observed in the T294A–T295A
mutant incubated with xPAK1 but not in the T294A–T295A–S349A
mutant. These results show that in vitro, under our experimental
conditions, Ser349 is the only phosphorylation site for xPAK1 on Xl-
Aurora-A.
Since xPAK1 speciﬁcally phosphorylates Aurora-A on Ser349, it is a
good way to study the consequence of this phosphorylation on the
activity of Aurora-A. We examined the kinase activity of wild type
Aurora after its phosphorylation by xPAK1. As shown in Fig. 2B (lane 2),
the phosphorylation of Aurora-A by xPAK1 reduced by 50% its kinase
activity. Similar result was observed when Aurora-A was phosphory-
lated by Xl-GSK3 (Fig. 2B lane 3), in agreement with a previous report
(Sarkissian et al., 2004). A similar pattern was observed when histone
H3 or MBP were used as substrates for the kinase, indicating that the
reduction of the kinase activity of Aurora-A phosphorylated on Ser349was not substrate dependent (Fig. 2B middle and lower panel). Alto-
gether, these observations indicated that the phosphorylation of the
Ser349 is responsible for a reduction of Aurora-A activity.
Is Aurora-A Ser349 phosphorylated during Xenopus oocyte maturation
A previous report has shown that Aurora-A Ser349 is phosphory-
lated in the presence of extracts of Xenopus oocytes (Littlepage et al.,
2002; Sarkissian et al., 2004). But there is no evidence for this phos-
phorylation event in vivo.
The anti-phospho-Ser349 antiserum was then used to investigate
the phosphorylation of Aurora-A Ser 349 during oocyte maturation.
Aurora-A was immunoprecipitated from extracts prepared from
immature oocytes (Prophase-arrested oocytes), from progesterone-
stimulated maturating oocytes (at the time of GVBD, 30 min post-
GVBD and 1 h post-GVBD) and from mature oocytes (metaphase II-
arrested oocytes). Immunoprecipitates were analyzed for Ser349
phosphorylation (Fig. 3A, upper panel) and Aurora-A content (Fig.
3A, upper middle panel) by western blot and for Aurora-A activity
using GST-p17 as substrate (Fig. 3A, lower middle panel). In parallel, to
conﬁrm the speciﬁcity of the signal, a western blot was performed
using the anti-phosphoSer349 antibody preabsorbed with the recom-
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Aurora-A protein increased as the oocytes entered GVBD and prog-
ressed until meiosis II arrest; in parallel the kinase activity showed a
biphasic proﬁle: it increased up to 30min after GVBD, dropped 1 h post
GVBD and reincreased in meiosis II arrested oocytes (Fig. 3A, upper
middle panel). As shown in Fig. 3A (upper panel), a signal correspond-
ing to the phosphorylation of Ser349 was detected as the oocytes
progressed in meiosis. A peak of phosphorylation on Ser349 was
observed 1 h post GVBD and the level dropped in MII arrested mature
oocytes. This peak of phosphorylation paralleled the decrease of
Aurora activity (Fig. 3B).
Is the Ser349 phosphorylation required during Xenopus oocyte
maturation?
To enlighten the function of the Ser349 and its phosphorylation
during oocyte maturation, oocytes were injected with the different
recombinant Aurora-A mutant proteins. The injected oocytes were
then stimulated with progesterone and checked at regular intervals
for appearance of the white spot in the animal hemisphere which
indicates the GVBD.
Each oocyte received by microinjection a quantity of recombinant
protein equivalent to the quantity of the endogenous protein, and
similar for all recombinant proteins (Fig. 4A). After stimulation with
progesterone, maturation was scored by the appearance of a white
spot, an indicator of germinal vesicle breakdown (Fig. 4B). For all re-
combinant proteins, a (GVBD)-50 (timewhen 50% of the oocytes show
a white spot) was determined (Fig. 4C).Fig. 4. Analysis of oocyte maturation after injection of the different recombinant Aurora-A p
100% MII arrested oocytes were processed for western blot using the speciﬁc 6E3 antibody di
injected with the dilution buffer (Merriam buffer) or 368 ng of the recombinant wild type (em
GVBDwasmonitored by the appearance of thewhite spot. The results are expressed asmeans±
were injected with 368 ng of the different recombinant Aurora-A proteins. Control oocytes
progesterone, the GVBD was monitored by the appearance of the white spot. The results in
deviations of 4 separate experiments. (D) Cytosolic extracts were prepared from all injected
buffer injected oocytes. Injected Aurora-A (His)6 proteins were immunoprecipitated with th
panel). Extracts from all injected oocytes were also tested for histone H1 kinase activity
(E) Morphology of the injected oocytes, at a time when control oocytes are arrested in metaK169R or T294A–T295A or T294A–T295A–S349Amutants-injected
oocytes reached (GVBD)-50 ∼1 h faster than the oocytes injected with
the dilution buffer alone. In contrast, oocytes injected either with the
wild-type or the S349A mutant had a kinetic similar to the control
oocytes (Figs. 4B and C).
Biochemical analysis were conducted to better understand the
effect of themicroinjected recombinantmutated protein on the oocyte
maturation. The MPF activity was determined by measuring the
Histone H1 kinase activity. As shown in Fig. 4D, the MPF was activated
in all microinjected oocytes (Fig. 4D middle panel). The MPF being a
key activity that catalyses entry into M-phase of meiosis I and meiosis
II, this indicates that the microinjected recombinant proteins did not
impair oocyte maturation. In addition, all microinjected oocytes ex-
pressed Cdc6, a factor undetectable in fully-grown oocytes but present
in mature oocytes. Then the microinjected recombinant proteins did
not prevent the meiosis to progress into metaphase II (Fig. 4D lower
panel).
The microscopic observation revealed that the conﬁguration of the
white spot was normal in oocytes injectedwith the T295A, the T294A–
T295A or the T294A–T295A–S349Amutants (Fig. 4E, panels e, f and g)
but was unusual in the other oocytes (Fig. 4E). In the wt-Aurora-A or
K169R mutant injected oocytes, the aspect of the maturing oocytes
differed from the control oocytes (Fig. 4E, compare panels b, c and d).
The white spot was translucent, the outline of the white spot was
shadowy, and the inside area deeply depigmented. The aspect of
oocytes injected with the S349A mutant was even more perturbed
with a discontinuous and blurry outline of the white spot and a depig-
mentation of the animal pole (Fig. 4E, panels h). In contrast to the otherroteins: (A) Two equivalent oocytes from all injected oocytes at a time corresponding to
rected against the recombinant protein. (B) Stage VI oocytes arrested in prophase I were
pty rhomb) or K169R mutant (full square) proteins. After addition of progesterone, the
standard deviation of 4 different experiments. (C) StageVI oocytes arrested inprophase I
were injected with the dilution buffer of the protein (Merriam buffer). After addition of
dicating the time necessary for reaching 50% GVBD are expressed as means±standard
oocytes at a time corresponding to 100% MII arrested oocytes observed for the dilution
e speciﬁc 6E3 antibody and tested for kinase activity with GST-p17 as substrate (upper
(middle panel). The presence of cdc6 was analysed by western blot (lower panel).
phase II.
529G. Pascreau et al. / Developmental Biology 317 (2008) 523–530oocytes, these latter underwent a degenerative process rapidly after
the appearance of the spot.
Discussion
Recombinant Aurora-A puriﬁed from bacteria was found phos-
phorylated on several residues (Haydon et al., 2003), but it was not
clear whether these sites were auto-phosphorylated or phosphory-
lated by bacterial kinases. In thiswork,we demonstrate that in absence
of other kinases, partner or substrate proteins, Thr295 is the only auto-
phosphorylation site. This residue located in the activation loop is
required for the activity of the kinase. Thr295 is part of a consensus
motif for phosphorylation by Aurora-A (…RRTT295L…) and this was
supported by the ability of the kinase to trans-phosphorylate another
molecule of kinase, as demonstrated in the in-gel kinase assay. On the
other hand Ser349 was neither trans-phosphorylated by Aurora-A nor
auto-phosphorylated, even though this residue is included in a similar
consensus motif (…RRIS349K…). However, Ser349 appears to be auto-
phosphorylated after the phosphorylation of the Ser290/Ser291 by Xl-
GSK-3 (Sarkissian et al., 2004). Altogether these data demonstrate that
Ser349 is part of a cryptic auto-phosphorylation site that requires
structural modiﬁcations induced by the phosphorylation of other
residues. Our data also shows that the auto-phosphorylation of Thr295
does not unveil this cryptic site.
Recombinant Aurora-A kinase Ser349 has been found phosphory-
lated in vitro in presence of Xenopus oocyte metaphase extract (Little-
page et al., 2002). This may be the result of the autophosphorylation
induced secondarily to the phosphorylation of the kinase by Xl-GSK3,
as described above. Nevertheless, it cannot be excluded that Ser349 is a
primephosphorylation site for other kinases present in the extract. The
sequence around Ser349 is similar to a consensus domain …xxRXSX
xx… found in Histone H3 (Ser10) and Raf-1 (Ser338). PAK1 (p21
activating kinase) serves as a physiological upstream kinase phosphor-
ylating these two serine residues (Li et al., 2002; Zang et al., 2002). Like
Aurora-A, PAK1 has been shown to be localized on and around the
spindles poles in the centrosomal region (Li et al., 2002), and as Aurora-
A, deregulation of PAK1 induces the formation of abnormal mitotic
spindle (Vadlamudi et al., 2000). Altogether, these observations lead us
to envisage that Xl-Aurora-A could be phosphorylated by xPAK1. Our
results demonstrate that in vitro Aurora-A Ser349 can be directly
phosphorylated by xPAK1, without other priming modiﬁcations.
xPAK1 has been shown to be present in Xenopus oocyte and to control
oocytemeioticmaturation (Faure et al.,1997; Faure et al.,1999). But the
physiological interaction between xPAK1 and Aurora-A in Xenopus
oocytes remains to be proved.
Ser349 is not a residue essential for the kinase activity of Aurora-A.
Indeed, the mutation of this residue into an alanine do not affect the
activity of the enzyme, as previously observed (Littlepage et al., 2002;
Sarkissian et al., 2004). In contrast, the phosphorylation of this residue
had some impact on the kinase activity. In agreement with a previous
report (Sarkissian et al., 2004), Aurora-A autophosphorylated on
Ser349 consecutively to the GSK-3-induced phosphorylation of
Ser290/Ser291 displayed a reduced kinase activity. A similar drop of
activity was provoked by the direct phosphorylation of Ser349 by
xPAK1. This last result singularly contrasts with a recent observation
made in human cells (Zhao et al., 2005). In NIH3T3 ﬁbroblasts, PAK1
has been described to be a potent activator of Aurora-A at the
centrosomes (Zhao et al., 2005). The authors showed that PAK1 binds
efﬁciently to the inactive Aurora-A and catalyzes its phosphorylation
on the Ser342 residue (a residue equivalent to the Ser349 in Xl-
Aurora-A), but also on the autophosphorylation sites Thr 288 (equi-
valent to the Thr295 residue in Xl-Aurora-A) causing an activation of
Aurora-A. The discrepancy between the 2 studies may rely upon the
association of Aurora-A to the centrosomes, since in Xenopus oocytes,
progesterone-triggered meiosis progression occurs in the absence of
centrosome.Aurora-A plays various functions during Xenopus oocyte meiotic
maturation, including meiotic spindle control (Castro et al., 2003;
Kinoshita et al., 2005; Liu and Ruderman, 2006; Peset et al., 2005;
Satinover et al., 2004) and translation regulation (Mendez et al., 2000;
Pascreau et al., 2005; Sarkissian et al., 2004). During progesterone
induced oocytematuration, Aurora-A is neo-synthesized at the time of
GVBD, then Aurora-A protein levels remain constant between meiosis
I and meiosis II. During this transition however, Aurora-A follows a
biphasic activation that is regulated by the phosphorylation of the
kinase (Ma et al., 2003). The transient inactivationwas correlated with
a dephosphorylation of the enzyme while inversely, its hyperpho-
sphorylation lead to its reactivation. In the present report, we focused
on Ser349 phosphorylation. This phosphorylation has been observed
in recombinant Aurora-A kinase incubated in presence of metaphase
extracts. Using a speciﬁc anti-phospho-Ser349 antiserum, we demon-
strate that Ser349 is phosphorylated in Xenopus oocytes and that its
level of phosphorylation ﬂuctuates during oocyte maturation. In
oocytes blocked in prophase of ﬁrst meiosis, the kinase appears to be
highly phosphorylated. The phosphorylation level drops after proges-
terone stimulation and reincreases transiently 1 h after GVBD at a time
when a drop of Aurora-A activity is observed. Because Ser349 phos-
phorylation is a negative regulator of Aurora kinase activity, these
results suggests that this event may participate to the transient in-
activation of Aurora-A observed during the meiotic transition.
To question the physiological function of Ser349 phosphorylation
during meiosis, we followed the maturation of oocytes injected with
the S349A Aurora-A mutant, a mutant missing the phosphorylable
Ser349. When compared to oocytes injected with a similar amount of
wild-type recombinant Aurora-A, the maturation kinetics was similar
in oocytes injected with the S349A mutants. The maturation was
complete in both cases as evidenced by the activation of H1 kinase and
the expression of Cdc6. However, the oocytes injected with the S349A
mutant showed a different pattern of pigmentation and degenerated
very quickly. In contrast, the oocytes injected with the T294A–T295A–
S349A mutant which also lacks the phosphorylable Ser349 but which
is devoid of any kinase activity, maturated quite normally without
showing any sign of degeneration. These observations indicate that the
maturation cannot be achieved properly with an excess of active
Aurora-A lacking the phosphorylable Ser349 residue. The absence of
Ser349 phosphorylation may prevent the negative regulation of
Aurora-A activity which occurs during the meiosis transition, leading
to unwanted phosphorylated substrate proteins.
In conclusion, we showed that: (1) in the absence of other proteins,
Ser349 is a site that is neither auto- nor trans-phosphorylated, (2)
Ser349 can be directly phosphorylated by xPAK1, and (3) the phos-
phorylation of Ser349 leads to a partial inactivation of Aurora-A
kinase. We also provide evidence that the phosphorylation of Ser349
could participate in the reduction of Aurora-A activity observed during
the meiosis I to meiosis II transition, and that this phosphorylation is
required for Xenopus oocytes to mature into fertilizable eggs.
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